Resmed Inc (RMD)
185.31 x 100 225.19 x 100
Post-market by (Cboe BZX)
212.91 +1.42 (+0.67%) 04/17/25 [NYSE]
185.31 x 100 225.19 x 100
Post-market 212.91 unch (unch) 16:10 ET
for Thu, Apr 17th, 2025
Results
download Want to compare other data? Select FieldsSymbol | RMD | HLN | A | ||
Company | Resmed Inc | Haleon Plc | Agilent Technologies | ||
Price Information | |||||
Exchange | NYSE | NYSE | NYSE | ||
Open | 209.00 | 10.16 | 102.63 | ||
High | 214.32 | 10.31 | 103.50 | ||
Low | 202.00 | 10.16 | 101.36 | ||
Last | 212.91 | 10.22 | 102.48 | ||
Change | +1.42 | +0.06 | -0.22 | ||
% Change | +0.67% | +0.59% | -0.21% | ||
Volume | 1,109,500 | 16,644,800 | 1,769,900 | ||
20-Day Average Volume | 1,248,885 | 13,632,595 | 2,660,345 | ||
Previous Close | 211.49 | 10.16 | 102.70 | ||
Industry | Medical Products | Medical Products | Medical Products | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 216.37 | 10.02 | 110.23 | ||
20-Day Raw Stochastic | 47.97% | 74.55% | 21.61% | ||
20-Day Relative Strength | 44.34% | 53.67% | 34.91% | ||
Weighted Alpha | +6.68 | +21.61 | -30.87 | ||
Today's Opinion | 88% Sell | 72% Buy | 100% Sell | ||
Previous Opinion | 88% Sell | 72% Buy | 100% Sell | ||
Last Month's Opinion | 72% Sell | 88% Buy | 72% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +1.12% since 04/10/25 | +6.13% since 04/10/25 | +2.53% since 04/10/25 | ||
Low | 202.00 on 04/17/25 | 9.82 on 04/11/25 | 98.86 on 04/11/25 | ||
High | 217.38 on 04/15/25 | 10.31 on 04/17/25 | 106.21 on 04/14/25 | ||
1-Month | |||||
%Chg | -5.26% since 03/17/25 | -0.87% since 03/17/25 | -16.34% since 03/17/25 | ||
Low | 199.92 on 04/07/25 | 9.18 on 04/09/25 | 96.43 on 04/09/25 | ||
High | 227.00 on 03/25/25 | 10.57 on 04/03/25 | 124.43 on 03/24/25 | ||
3-Month | |||||
%Chg | -11.21% since 01/17/25 | +10.61% since 01/17/25 | -30.46% since 01/17/25 | ||
Low | 199.92 on 04/07/25 | 9.16 on 01/21/25 | 96.43 on 04/09/25 | ||
High | 263.05 on 01/30/25 | 10.79 on 03/04/25 | 153.84 on 01/31/25 | ||
6-Month | |||||
%Chg | -11.14% since 10/17/24 | +1.39% since 10/17/24 | -25.43% since 10/17/24 | ||
Low | 199.92 on 04/07/25 | 8.86 on 01/14/25 | 96.43 on 04/09/25 | ||
High | 263.05 on 01/30/25 | 10.79 on 03/04/25 | 153.84 on 01/31/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 31,269,456 | 46,151,404 | 29,217,356 | ||
Shares Outstanding, K | 146,867 | 4,515,793 | 285,103 | ||
Annual Sales | 4,685,300,000 | 14,354,650,000 | 6,510,000,000 | ||
Annual Net Income | 1,020,950,000 | 1,842,730,000 | 1,289,000,000 | ||
Last Quarter Sales | 1,282,090,000 | 3,535,470,000 | 1,681,000,000 | ||
Last Quarter Net Income | 344,620,000 | 296,010,000 | 318,000,000 | ||
60-Month Beta | 0.75 | 0.24 | 1.19 | ||
Per-Share Information | |||||
Most Recent Earnings | 2.43 on 01/30/25 | 0.05 on 02/27/25 | 1.31 on 02/26/25 | ||
Latest Earnings Date | 04/23/25 | 05/07/25 | 05/28/25 | ||
Most Recent Dividend | 0.530 on 02/13/25 | 0.053 on 08/16/24 | 0.248 on 04/01/25 | ||
Next Ex-Dividends Date | 02/13/25 | 04/25/25 | 04/01/25 | ||
Ratios | |||||
Price/Earnings ttm | 23.92 | 26.05 | 19.34 |